Designing labels and websites that avoid implied drug claims


Published on 04/12/2025

Designing Labels and Websites that Avoid Implied Drug Claims

The regulatory landscape governing dietary supplements is complex, particularly when it comes to labeling and marketing. One of the key areas of compliance revolves around distinguishing between structure/function claims and disease claims. Understanding these distinctions is critical for regulatory, QA, QC, and compliance professionals in dietary supplements and nutrition brands.

Understanding Structure/Function Claims vs Disease Claims

The FDA delineates between structure/function claims and disease claims under the Dietary Supplement Health and Education Act (DSHEA). Structure/function claims describe the role of a dietary ingredient in affecting the structure or function of the body. For instance, a claim stating that calcium is necessary for maintaining healthy bones qualifies as a structure/function claim.

Disease claims, conversely, imply that a product can reduce the risk

of a disease or treat, cure, or prevent a disease. An assertion such as, “This supplement helps lower cholesterol” crosses the line into disease claim territory. This distinction is fundamental because the regulatory standards for each category are markedly different.

In the U.S., structure/function claims must be truthful and not misleading, and manufacturers are required to have substantiation for any claims made. All such claims must also bear a disclaimer indicating that the FDA has not evaluated the claim, and that the dietary supplement is not intended to diagnose, treat, cure, or prevent any disease.

Navigating FDA Claim Rules

Adhering to FDA claim rules is essential to avoid potential warning letters or other regulatory actions. The key steps in navigating these rules include:

  • Step 1: Familiarize Yourself with Regulations – Understand relevant provisions in 21 CFR 101.93, which outlines the requirements for structure/function claims. This regulation details what constitutes acceptable claims and the required disclaimers.
  • Step 2: Claim Substantiation – Ensure you have adequate evidence to support your claims. This could include clinical studies, scientific literature, or expert opinions. Claims must not only be substantiated but also must be verifiable.
  • Step 3: Label Compliance – Ensure the product label includes proper disclaimers. For structure/function claims, it is critical to include a statement like, “This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.” This helps clarify the intent behind the claims and manages consumer expectations.
  • Step 4: Engage in Marketing Review – Before launching a product, implement a comprehensive marketing review process to ensure all advertising, promotional materials, and claims are compliant with FDA guidelines. This should be ongoing, as new interpretations of the rules can emerge.
See also  SaMD versus SiMD understanding FDA terminology and regulatory impact

Case Studies and Consequences of Non-Compliance

Understanding the implications of non-compliance provides insight into the importance of adhering to FDA regulations. Various dietary supplement companies have faced significant penalties due to mislabeling or making improper claims.

For example, there have been instances where companies made disease claims about their products leading to FDA warning letters. These letters typically detail the nature of the violation, which may include unsubstantiated claims and failure to provide adequate disclaimer language. Without proper compliance, companies not only face legal action but also the potential for damage to their reputation and loss of consumer trust.

It is crucial to regularly monitor FDA warning letters and guidance documents to stay updated with the most recent compliance interpretations. By doing so, a company can learn from the mistakes of others and take preemptive action to avoid similar pitfalls.

Regulatory Review: The Role of QA and QC Professionals

Regulatory, QA, and QC professionals play a pivotal role in ensuring compliance with labeling requirements. The expectations around structured reviews and checks are essential to maintain product integrity and regulatory alignment.

The critical components of a QA/QC review process include:

  • Documentation Review – Review all labeling documentation to ensure alignment with FDA regulations and that all claims are substantiated.
  • Training – Ongoing training for staff on FDA claim rules helps maintain a culture of compliance. Regular workshops and updates can keep teams informed of the latest developments.
  • Internal Audits – Conducting periodic internal audits can help identify potential compliance issues before they become significant problems, allowing for timely corrective actions.
See also  How clinical data and literature reviews support structure function claims

Positioning Your Product: Marketing and Online Presence

The digital landscape has amplified the need for compliance in marketing and online presences. Websites and promotional content must not only comply with labeling requirements but also provide clear, honest information about dietary supplements.

Common pitfalls in online marketing include:

  • Misleading Statements – Avoid language that may induce consumers to interpret a structure/function claim as a disease claim. For instance, avoid using phrases like “promotes health” when it could imply the prevention of disease.
  • Testimonials – Be cautious when using customer testimonials. If testimonials imply disease claims or outcomes not substantiated, this can lead to regulatory scrutiny.

Life Cycle of a Dietary Supplement: Compliance from Production to Marketing

Compliance is not just about post-market surveillance but begins at the very start of a dietary supplement’s development. Each stage of the product life cycle seeks to integrate understanding and adherence to FDA regulations.

1. Formulation and Development: At this phase, it is essential to determine the intended structure/function claims based on the ingredients and their established functions, guided by existing scientific evidence.

2. Label Design: Design labels to include appropriate disclaimers. Marketing teams should collaborate with regulation specialists to ensure that all claims are adequately documented and substantiated.

3. Manufacturing Compliance: Ensure that Good Manufacturing Practices (GMP) are strictly followed as per 21 CFR Part 111, ensuring product consistency and compliance.

4. Market Launch and Oversight: Monitor market feedback and sales channels for compliance, gathering insights into how products are viewed by consumers and conducting necessary adjustments.

Conclusion: Ensuring Compliance and Avoiding Implications

In conclusion, the distinction between structure/function claims and disease claims is vital in the regulatory assessment of dietary supplements. A robust understanding of FDA claim rules, along with adherence to the guidelines, can mitigate risks and foster compliance.

See also  Claim hierarchy strategy for packaging, websites and paid advertising

Marketing and regulatory professionals must work closely to fortify their claims substantiation processes, implement comprehensive training programs, and maintain an active commitment to staying informed about FDA expectations. By prioritizing comprehensive compliance strategies, dietary supplement companies can navigate the intricate landscape of regulatory requirements effectively.